Sandu Pharmaceuticals Ltd Q1FY22 PAT at Rs. 41.82 lakhs

Sandu Pharmaceuticals Ltd. has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.17.35 crores during the period ended June 30, 2021 as compared to Rs.14.12 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.4182 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.4613 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.48 for the period ended June 30, 2021 as compared to Rs.0.65 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 17.35 crs	₹ 14.12 crs	22.88%
Net Profit	₹ 0.4182 crs	₹ 0.4613 crs	-9.34%
EPS	₹ 0.48	₹ 0.65	-26.15%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.17.35 crores during the period ended June 30, 2021 as compared to Rs.11.69 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.0.4182 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.0380 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.0.48 for the period ended June 30, 2021 as compared to Rs.0.05 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 17.35 crs	₹ 11.69 crs	48.42%
Net Profit	₹ 0.4182 crs	₹ 0.0380 crs	1000.53%
EPS	₹ 0.48	₹ 0.05	860%

Shares of Sandu Pharmaceuticals Ltd. was last trading in BSE at Rs. 53.6 as compared to the previous close of Rs. 51.6. The total number of shares traded during the day was 13656 in over 93 trades.

The stock hit an intraday high of Rs. 59 and intraday low of 53.3. The net turnover during the day was Rs. 739896.

Source : Equity Bulls

Keywords